VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
3.155
+0.025 (0.80%)
At close: Nov 7, 2024, 4:00 PM
3.110
-0.045 (-1.43%)
After-hours: Nov 7, 2024, 6:01 PM EST
VYNE Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 7, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 47 | 33 | 9 | 55 | 265 | - | |
| Market Cap Growth | 109.26% | 273.57% | -84.05% | -79.42% | - | - | |
| Enterprise Value | -32 | 17 | -27 | 3 | 224 | - | |
| Last Close Price | 3.13 | 2.33 | 2.70 | 18.36 | 113.76 | - | |
| PE Ratio | - | -0.84 | -0.37 | -0.72 | -0.80 | - | |
| PS Ratio | 192.78 | 76.70 | 18.25 | 58.63 | 12.64 | - | |
| PB Ratio | 0.61 | 0.37 | 0.28 | 1.12 | 7.07 | - | |
| P/FCF Ratio | - | -1.28 | -0.30 | -0.97 | -1.93 | - | |
| P/OCF Ratio | - | -1.28 | -0.30 | -0.97 | -1.93 | - | |
| EV/Sales Ratio | -101.88 | 40.27 | -56.19 | 3.58 | 10.69 | - | |
| EV/EBITDA Ratio | - | -0.58 | 0.78 | -0.09 | -1.98 | - | |
| EV/EBIT Ratio | 1.33 | -0.58 | 0.78 | -0.09 | -1.98 | - | |
| EV/FCF Ratio | - | -0.67 | 0.92 | -0.06 | -1.64 | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | - | 0.01 | 0.93 | 1.96 | |
| Debt / FCF Ratio | - | -0.01 | - | -0.01 | -0.25 | -0.46 | |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.24 | 0.00 | |
| Inventory Turnover | - | - | - | - | 0.32 | - | |
| Quick Ratio | 5.54 | 12.37 | 3.84 | 2.71 | 3.42 | 2.46 | |
| Current Ratio | 5.81 | 12.73 | 4.10 | 3.43 | 4.01 | 2.61 | |
| Return on Equity (ROE) | -90.47% | -46.40% | -84.81% | -102.66% | -928.19% | -173.43% | |
| Return on Assets (ROA) | -49.36% | -26.42% | -39.77% | -30.25% | -81.10% | -64.82% | |
| Return on Capital (ROIC) | -62.69% | -30.39% | -53.32% | -40.11% | -114.09% | -83.09% | |
| Earnings Yield | -72.24% | -87.49% | -266.62% | -134.33% | -96.35% | - | |
| FCF Yield | -56.59% | -77.92% | -335.43% | -103.26% | -51.72% | - | |
| Buyback Yield / Dilution | -822.56% | -222.44% | -11.44% | -58.75% | -282.06% | -31.22% | |
| Total Shareholder Return | -822.56% | -222.44% | -11.44% | -58.75% | -282.06% | -31.22% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.